ConvergeHEALTH Miner™ Access Suite

The importance of linking strategy and operations

You know the saying, “You only get one chance to make a first impression”? Well, here is a similar one for pharmaceutical manufacturers: “You only get one chance to set a product’s launch price.”

Formulating an effective pricing strategy is critical to help ensure that a new product is accessible to patients and fulfills business objectives. The process is complex; the manufacturer must set both list and contract prices while being thoughtful about business objectives and competitive market dynamics.

In addition, a new environment is emerging that may upend pharmaceutical product pricing and contracting, requiring a new generation of contract life cycle management solutions. The driving forces include the following:

• Shifting company portfolios
• Drugs with multiple indications
• Drug approval process acceleration
• The introduction of cell and gene therapies
• An increasing push to manage product pricing and contracting globally

The time has come to make the process, technology, and operating model changes needed to realize the business benefits of effectively orchestrating the end-to-end pricing and contracting life cycle. Learn how integrating strategy and operations, with the help of a modernized-integrated pricing and management solution, can help you achieve product pricing and contracting success.

Miner Access: Deal, pricing, and value-based analytics

ConvergeHEALTH Miner™ Access Suite is an integrated and intuitive suite for overall pricing, market access, and reimbursement decision support at scale. Deal and pharmaceutical pricing analytics leverage overlapping data elements and interoperability to create a decision support tool for improved pricing and reimbursement strategies.

ConvergeHEALTH Miner Access Suite

With the ConvergeHEALTH Miner™ Access Suite, data science is used within an integrated platform that helps organizations define and anticipate the impact of contracting and pricing relationships. This enables increased market access and improved outcomes, including reimbursement, through the following modules:

• Deal analytics:

1. Pre-deal modeling: Enhanced use of third-party data and AI techniques to enable robust predictive capabilities and meaningful benchmarks to clarify business decisions related to managed care contracting agreements

2. Post-deal monitoring and analytics: Application of data-driven analytics to understand the root cause of contract performance, enabling real-time market moves

• Pricing analytics: Management of the pricing adjustment intricacies in light of contractual agreements and state price transparency laws
• Value-based analytics: Streamlining the operational complexities of value-based agreements, enabling implementation of these new agreements at scale

ConvergeHEALTH Miner™: Data and analytics at scale

How do life sciences companies turn real-world data into insights that can drive more value for their organizations? ConvergeHEALTH Miner™ is an award-winning platform that transforms how medical innovations are developed, commercialized, and reimbursed. Explore how ConvergeHEALTH Miner™, composed of the Access suite detailed above and the Evidence suite, is generating value across the entire product life cycle.

An end-to-end evidence generation capability is becoming critical to the future success of the industry and must address four fundamental challenges:

• How do we effectively manage all of this disparate digital health data?
• How can we rapidly generate insights from them?
• How can we empower more stakeholders to leverage data and insights?
• How do we act on these insights to drive decision-making?

…and how do we do this at scale?